abstract |
The present invention is generally directed to Inhibitor of Apoptosis Proteins ('IAPs'), nucleic acid molecules encoding IAPs, viral vectors, recombinant baculoviruses comprising an IAP, transgenic plants comprising an IAP nucleic acid, and methods of assaying for compounds which bind to an IAP. In general, the IAP nucleic acids of the invention have 85 % or higher identity to SEQ ID NO:1 and the IAP of the invention have 90 % or higher identity to SEQ ID NO:3. |